Pneumonia after kidney transplant: Incidence, risk factors, and mortality
dc.contributor.author | Dizdar, Oğuzhan Sıtkı | |
dc.contributor.buuauthor | Ersoy, Alparslan | |
dc.contributor.buuauthor | Akalın, Halis | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Mikrobiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-0710-0923 | tr_TR |
dc.contributor.researcherid | AAH-5054-2021 | tr_TR |
dc.contributor.researcherid | AAU-8952-2020 | tr_TR |
dc.contributor.scopusid | 35612977100 | tr_TR |
dc.contributor.scopusid | 57207553671 | tr_TR |
dc.date.accessioned | 2022-09-01T10:43:59Z | |
dc.date.available | 2022-09-01T10:43:59Z | |
dc.date.issued | 2014-06 | |
dc.description.abstract | Objectives: Pneumonia is an important cause of morbidity and mortality in recipients of solid-organ transplant. We aimed to determine risk factors for development of pneumonia and associated deaths in kidney transplant recipients. Materials and Methods: A retrospective review of medical records was performed for all kidney transplant recipients from December 1988, to April 2011. The diagnosis of community-acquired pneumonia was made from symptoms, clinical findings, and chest radiography. The diagnosis of nosocomial pneumonia was made according to published criteria. Laboratory and serologic tests, radiographic findings, cultures of respiratory specimens, and tissue biopsies were reviewed. Results: In 406 kidney transplant recipients, there were 82 patients (20%) who had 111 episodes of pneumonia, including 49 nosocomial episodes of pneumonia (44%). Bacterial infections were the most common cause (34 episodes [31%]). In multivariate analysis, significant risk factors associated with pneumonia episodes were older age, hypertension, cardiac disease, history of acute graft rejection, and not using everolimus/mycophenolate mofetil/prednisolone protocol. There were 28 episodes that resulted in death (25%), including 20 nosocomial episodes (71%). In multivariate analysis, significant risk factors associated with death from pneumonia episodes were antibiotic use in the previous 3 months, high C-reactive protein, and low albumin. Cutoff values for increased risk of death from pneumonia included C-reactive protein > 10 mg/dL and procalcitonin > 8.8 ng/mL. Conclusions: Recipients of kidney transplant may be at risk for pneumonia and associated death. Nosocomial pulmonary infections may be associated with marked morbidity and mortality in kidney transplant recipients. | en_US |
dc.identifier.citation | Dizdar, O. S. vd. (2014). "Pneumonia after kidney transplant: Incidence, risk factors, and mortality". Experimental and Clinical Transplantation, 12(3), 205-211. | tr_TR |
dc.identifier.endpage | 211 | tr_TR |
dc.identifier.issn | 1304-0855 | |
dc.identifier.issue | 3 | tr_TR |
dc.identifier.pubmed | 24907720 | tr_TR |
dc.identifier.scopus | 2-s2.0-84901915171 | tr_TR |
dc.identifier.startpage | 205 | tr_TR |
dc.identifier.uri | https://doi.org/10.6002/ect.2013.0093 | |
dc.identifier.uri | http://ectrx.org/forms/ectrxcontentshow.php?doi_id=10.6002/ect.2013.0093 | |
dc.identifier.uri | http://hdl.handle.net/11452/28422 | |
dc.identifier.volume | 12 | tr_TR |
dc.identifier.wos | 000337655800006 | tr_TR |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Başkent Üniversitesi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | Experimental and Clinical Transplantation | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Renal failure | en_US |
dc.subject | Nephrology | en_US |
dc.subject | Lung | en_US |
dc.subject | Infection | en_US |
dc.subject | Community-acquired pneumonia | en_US |
dc.subject | Pulmonary infections | en_US |
dc.subject | Recipients | en_US |
dc.subject | Validation | en_US |
dc.subject | Bacterial | en_US |
dc.subject | Failure | en_US |
dc.subject | Transplantation | en_US |
dc.subject.emtree | Aciclovir | en_US |
dc.subject.emtree | Albumin | en_US |
dc.subject.emtree | Azathioprine | en_US |
dc.subject.emtree | C reactive protein | en_US |
dc.subject.emtree | Cephalosporin | en_US |
dc.subject.emtree | Cotrimoxazole | en_US |
dc.subject.emtree | Cyclosporin | en_US |
dc.subject.emtree | Everolimus | en_US |
dc.subject.emtree | Interleukin 2 receptor antibody | en_US |
dc.subject.emtree | Isoniazid | en_US |
dc.subject.emtree | Methylprednisolone | en_US |
dc.subject.emtree | Mycophenolic acid 2 morpholinoethyl ester | en_US |
dc.subject.emtree | Prednisolone | en_US |
dc.subject.emtree | Rapamycin | en_US |
dc.subject.emtree | Tacrolimus | en_US |
dc.subject.emtree | Thymocyte antibody | en_US |
dc.subject.emtree | Valganciclovir | en_US |
dc.subject.emtree | Acute graft rejection | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Age | en_US |
dc.subject.emtree | Antibody titer | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Aspergillus fumigatus | en_US |
dc.subject.emtree | Chronic graft rejection | en_US |
dc.subject.emtree | Clinical feature | en_US |
dc.subject.emtree | Clinical protocol | en_US |
dc.subject.emtree | Community acquired pneumonia | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Delayed graft function | en_US |
dc.subject.emtree | Diastolic blood pressure | en_US |
dc.subject.emtree | Disease severity | en_US |
dc.subject.emtree | Drug use | en_US |
dc.subject.emtree | Drug withdrawal | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Fiberoptic bronchoscopy | en_US |
dc.subject.emtree | Haemophilus influenzae | en_US |
dc.subject.emtree | Heart disease | en_US |
dc.subject.emtree | Hospital infection | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human tissue | en_US |
dc.subject.emtree | Hypertension | en_US |
dc.subject.emtree | Immunosuppressive treatment | en_US |
dc.subject.emtree | Incidence | en_US |
dc.subject.emtree | Kidney transplantation | en_US |
dc.subject.emtree | Length of stay | en_US |
dc.subject.emtree | Loading drug dose | en_US |
dc.subject.emtree | Lung lavage | en_US |
dc.subject.emtree | Lung mycosis | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Medical record | en_US |
dc.subject.emtree | Morbidity | en_US |
dc.subject.emtree | Mortality | en_US |
dc.subject.emtree | Pneumocystis pneumonia | en_US |
dc.subject.emtree | Pseudomonas aeruginosa | en_US |
dc.subject.emtree | Retrospective study | en_US |
dc.subject.emtree | Risk factor | en_US |
dc.subject.emtree | Sensitivity and specificity | en_US |
dc.subject.emtree | Single drug dose | en_US |
dc.subject.emtree | Stenotrophomonas maltophilia | en_US |
dc.subject.emtree | Systolic blood pressure | en_US |
dc.subject.emtree | Thorax radiography | en_US |
dc.subject.emtree | Chi square distribution | en_US |
dc.subject.emtree | Community-acquired infections | en_US |
dc.subject.emtree | Comorbidity | en_US |
dc.subject.emtree | Cross infection | en_US |
dc.subject.emtree | Epidemiology | en_US |
dc.subject.emtree | Graft rejection | tr_TR |
dc.subject.emtree | Kaplan Meier method | en_US |
dc.subject.emtree | Kidney transplantation | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Mortality | en_US |
dc.subject.emtree | Multivariate analysis | en_US |
dc.subject.emtree | Pneumonia | en_US |
dc.subject.emtree | Prognosis | en_US |
dc.subject.emtree | Risk | en_US |
dc.subject.emtree | Statistical model | en_US |
dc.subject.emtree | Time | en_US |
dc.subject.emtree | Turkey | en_US |
dc.subject.emtree | Young adult | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Age factors | en_US |
dc.subject.mesh | Chi-square distribution | en_US |
dc.subject.mesh | Community-acquired infections | en_US |
dc.subject.mesh | Comorbidity | en_US |
dc.subject.mesh | Cross infection | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Graft rejection | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Incidence | en_US |
dc.subject.mesh | Kaplan-Meier estimate | en_US |
dc.subject.mesh | Kidney transplantation | en_US |
dc.subject.mesh | Logistic models | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Multivariate analysis | en_US |
dc.subject.mesh | Odds ratio | en_US |
dc.subject.mesh | Pneumonia | en_US |
dc.subject.mesh | Prognosis | en_US |
dc.subject.mesh | Retrospective studies | en_US |
dc.subject.mesh | Risk factors | en_US |
dc.subject.mesh | Time factors | en_US |
dc.subject.mesh | Turkey | en_US |
dc.subject.mesh | Young adult | en_US |
dc.subject.scopus | Transplant Recipients; Urinary Tract Infections; Kidney Transplantation | en_US |
dc.subject.wos | Transplantation | en_US |
dc.title | Pneumonia after kidney transplant: Incidence, risk factors, and mortality | en_US |
dc.type | Article | |
dc.wos.quartile | Q4 | en_US |